#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4199595	F	Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay	Leishmania infantum	31	ALA4196114	organism-based format	Scientific Literature
2.	ALA4199596	F	Antileishmanial activity against Leishmania tropica MHOM/IT/2012/ISS3130 promastigotes after 72 hrs by MTT assay	Leishmania tropica	31	ALA4196114	organism-based format	Scientific Literature
3.	ALA4199597	A	Cytotoxicity against PMA-differentiated human THP1 cells after 72 hrs by MTT assay	Homo sapiens	31	ALA4196114	cell-based format	Scientific Literature
4.	ALA4199598	T	Selectivity index, ratio of IC50 for PMA-differentiated human THP1 cells to IC50 for Leishmania infantum MHOM/TN/80/IPT1 promastigotes		31	ALA4196114	assay format	Scientific Literature
5.	ALA4199599	T	Selectivity index, ratio of IC50 for PMA-differentiated human THP1 cells to IC50 for Leishmania tropica MHOM/IT/2012/ISS3130 promastigotes		31	ALA4196114	assay format	Scientific Literature
6.	ALA4199600	F	Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth at 0.5 uM after 72 hrs by Giemsa staining based light microscopy relative to control	Leishmania infantum	11	ALA4196114	organism-based format	Scientific Literature
7.	ALA4199601	F	Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy	Leishmania infantum	11	ALA4196114	organism-based format	Scientific Literature
8.	ALA4199602	T	Selectivity index, ratio of IC50 for PMA-differentiated human THP1 cells to IC50 for amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells		11	ALA4196114	assay format	Scientific Literature
9.	ALA4199603	T	Toxicity in C57Bl/6 mouse assessed as survival at 300 mg/kg, po administered as single dose measured twice daily up to 30 days	Mus musculus	3	ALA4196114	organism-based format	Scientific Literature
10.	ALA4199604	T	Toxicity in C57Bl/6 mouse assessed as survival at 50 mg/kg, sc administered as single dose measured twice daily up to 30 days	Mus musculus	1	ALA4196114	organism-based format	Scientific Literature
11.	ALA4199605	T	Toxicity in C57Bl/6 mouse assessed as effect on normal appearance at 300 mg/kg, po administered as single dose measured twice daily up to 30 days	Mus musculus	2	ALA4196114	organism-based format	Scientific Literature
12.	ALA4199606	T	Toxicity in C57Bl/6 mouse assessed as effect on normal appearance at 15 mg/kg, sc administered as single dose measured twice daily up to 30 days	Mus musculus	1	ALA4196114	organism-based format	Scientific Literature
13.	ALA4199607	T	Toxicity in C57Bl/6 mouse assessed as effect on normal behavior at 300 mg/kg, po administered as single dose measured twice daily up to 30 days	Mus musculus	2	ALA4196114	organism-based format	Scientific Literature
14.	ALA4199608	T	Toxicity in C57Bl/6 mouse assessed as effect on normal behavior at 15 mg/kg, sc administered as single dose measured twice daily up to 30 days	Mus musculus	1	ALA4196114	organism-based format	Scientific Literature
15.	ALA4199609	F	Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in Balb/c mouse assessed as reduction in liver parasite load at 50 mg/kg, po administered for 4 days measured post last dose relative to control	Leishmania infantum	1	ALA4196114	organism-based format	Scientific Literature
16.	ALA4199610	F	Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in Balb/c mouse assessed as reduction in liver parasite load at 100 mg/kg, po administered for 4 days measured post last dose relative to control	Leishmania infantum	2	ALA4196114	organism-based format	Scientific Literature
17.	ALA4199615	F	Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in Balb/c mouse assessed as reduction in liver parasite load at 1 to 5 mg/kg, sc administered for 5 days measured post last dose relative to control	Leishmania infantum	1	ALA4196114	organism-based format	Scientific Literature
18.	ALA4199616	F	Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in po dosed Balb/c mouse assessed as reduction in liver parasite load administered for 4 to 5 days measured post last dose	Leishmania infantum	2	ALA4196114	organism-based format	Scientific Literature
19.	ALA4199617	F	Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in sc dosed Balb/c mouse assessed as reduction in liver parasite load administered for 4 to 5 days measured post last dose	Leishmania infantum	2	ALA4196114	organism-based format	Scientific Literature
20.	ALA4199618	F	Induction of nitric oxide production in IFNgamma-primed mouse BMDM measured after 24 hrs by Griess assay	Mus musculus	2	ALA4196114	cell-based format	Scientific Literature